Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy

D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1652
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Choy (South San Francisco, United States of America), N. Trivedi (San Francisco, United States of America), A. Dressen (South San Francisco, United States of America), M. Babina (Berlin, Germany), R. Ahuja (San Francisco, United States of America), T. Yi (South San Francisco, United States of America), J. Jackman (South San Francisco, United States of America), G. Ji (South San Francisco, United States of America), J. Hackney (South San Francisco, United States of America), L. Orozco-Guerra (South San Francisco, United States of America), D. Chang (South San Francisco, United States of America), G. Caughey (San Francisco, United States of America), B. Yaspan (San Francisco, United States of America). Tryptase loss-of-function mutations reduce tryptase expression and predict asthmatic response to anti-IgE therapy. 1652

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy
Source: Eur Respir J, 58 (6) 2003969; 10.1183/13993003.03969-2020
Year: 2021



Do leukotriene antagonists reduce eosinophil numbers in induced sputum from asthmatic patients as a consequence of increased apoptosis induction?
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002

PP115 – COL4A3 degradation predicts anti-IgE response in severe asthma
Source: ERS Lung Science Conference 2021
Year: 2021

A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006


The effect of GSK2190915, a 5-lipoxygenase activating protein inhibitor, on the early asthmatic response to inhaled allergen
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients?
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Aspirin enhances the CD11b expression of eosinophils in patients with aspirin-intolerance asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003

Sputum gene expression of mast cell tryptase and carboxypeptidase A3 are increased in eosinophilic asthma
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Differential expression of mRNA encoding for pro-inflammatory and angiogenic proteins in aspirin-tolerant and -intolerant asthma, following oral provocative aspirin challenge
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Allergen immunotherapy induces a suppressor memory response that is mediated by IL-10 in a mouse model of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003

Recruitment of eosinophils and increased expression of mast cells tryptase in the bronchial mucosa of patients with allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002

Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Differential gene expression and cytokine production from neutrophils in asthma phenotypes
Source: Eur Respir J 2010; 35: 522-531
Year: 2010



Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011


The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019


Anti-IL-5 antibody reduces the increase of CD34+ eosinophils in a mouse model of airway allergic eosinophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011

Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice
Source: Eur Respir J 2006; 28: Suppl. 50, 224s
Year: 2006